nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparative study of anti–ADAMTS-13 antibody dynamics in immune-mediated thrombotic thrombocytopenic purpura
|
Cozzi, Maria Rita |
|
|
8 |
5 |
p. |
artikel |
2 |
A machine learning model for early and accurate prediction of overt disseminated intravascular coagulation before its progression to an overt stage
|
Umemura, Yutaka |
|
|
8 |
5 |
p. |
artikel |
3 |
A rare case of acquired von Willebrand syndrome type 2B: diagnosis, treatment, and underlying pathophysiology
|
Jaouen, Simon |
|
|
8 |
5 |
p. |
artikel |
4 |
Ascertaining accurate exposure to aspirin and other antithrombotic medications using structured electronic health record data
|
Gergi, Mansour |
|
|
8 |
5 |
p. |
artikel |
5 |
Bleeding in valvular heart disease: is von Willebrand factor the culprit?
|
Bakhtari, Shirin |
|
|
8 |
5 |
p. |
artikel |
6 |
Caplacizumab improves clinical outcomes and is well tolerated across clinically relevant subgroups of patients with immune-mediated thrombotic thrombocytopenic purpura
|
Pavenski, Katerina |
|
|
8 |
5 |
p. |
artikel |
7 |
Editorial Board
|
|
|
|
8 |
5 |
p. |
artikel |
8 |
Electronic consultation to improve care outcomes in patients with suspected and confirmed heparin-induced thrombocytopenia
|
May, Jori E. |
|
|
8 |
5 |
p. |
artikel |
9 |
Erratum to ‘Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress’ [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]
|
Ward, Chris |
|
|
8 |
5 |
p. |
artikel |
10 |
Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy
|
Yamada, Shinya |
|
|
8 |
5 |
p. |
artikel |
11 |
Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial
|
Ogihara, Yoshito |
|
|
8 |
5 |
p. |
artikel |
12 |
Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus
|
Sabljic, Nikica |
|
|
8 |
5 |
p. |
artikel |
13 |
Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study
|
Nagao, Azusa |
|
|
8 |
5 |
p. |
artikel |
14 |
Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods
|
Gehlen, Rachel |
|
|
8 |
5 |
p. |
artikel |
15 |
In vitro assessment of the risk of ABCB1-mediated drug–drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell lines
|
Mahieu, Gwenaëlle |
|
|
8 |
5 |
p. |
artikel |
16 |
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial
|
Fumagalli, Riccardo M. |
|
|
8 |
5 |
p. |
artikel |
17 |
Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study
|
Arunothai, Saengrawee |
|
|
8 |
5 |
p. |
artikel |
18 |
Managing surgical relapse risk in acquired thrombotic thrombocytopenic purpura: a systematic review
|
Pinheiro Maux Lessa, Morgana |
|
|
8 |
5 |
p. |
artikel |
19 |
Modeling cancer-associated hypercoagulability using glioblastoma spheroids in microfluidic chips
|
Kapteijn, Maaike Y. |
|
|
8 |
5 |
p. |
artikel |
20 |
Multiparameter phenotyping of platelets and characterization of the effects of agonists using machine learning
|
Vadgama, Ami |
|
|
8 |
5 |
p. |
artikel |
21 |
Navigating the inevitable: artificial intelligence and the future of scientific communication
|
Makris, Michael |
|
|
8 |
5 |
p. |
artikel |
22 |
Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis
|
Punt, Marieke |
|
|
8 |
5 |
p. |
artikel |
23 |
Quality of life in oncological patients with venous thromboembolic disease
|
Arteaga, Andrea Jimena Morales |
|
|
8 |
5 |
p. |
artikel |
24 |
Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany
|
Bidlingmaier, Christoph |
|
|
8 |
5 |
p. |
artikel |
25 |
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial
|
Mittal, Prabal |
|
|
8 |
5 |
p. |
artikel |
26 |
Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies
|
Riva, Nicoletta |
|
|
8 |
5 |
p. |
artikel |
27 |
Serum albumin, genetic susceptibility, and risk of venous thromboembolism
|
Sun, Yuyang |
|
|
8 |
5 |
p. |
artikel |
28 |
Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk
|
Brook, Rowena |
|
|
8 |
5 |
p. |
artikel |
29 |
Syndemics in women’s health: poverty, social exclusion, and clustering of thrombotic and hemostasis disorders
|
O’Rourke, Ellen |
|
|
8 |
5 |
p. |
artikel |
30 |
The association between unemployment and treatment among adults with hemophilia
|
Qvigstad, Christian |
|
|
8 |
5 |
p. |
artikel |
31 |
The association of antiplatelet agents with mortality among patients with non–COVID-19 community-acquired pneumonia: a systematic review and meta-analysis
|
Lother, Sylvain A. |
|
|
8 |
5 |
p. |
artikel |
32 |
Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis
|
van der Bom, Johanna G. |
|
|
8 |
5 |
p. |
artikel |
33 |
Transmembrane thiol isomerase TMX1 counterbalances the effect of ERp46 to inhibit platelet activation and integrin αIIbβ3 function
|
Zhao, Zhenzhen |
|
|
8 |
5 |
p. |
artikel |